» Articles » PMID: 23092393

Correlation Analyses of Clinical and Molecular Findings Identify Candidate Biological Pathways in Systemic Juvenile Idiopathic Arthritis

Abstract

Background: Clinicians have long appreciated the distinct phenotype of systemic juvenile idiopathic arthritis (SJIA) compared to polyarticular juvenile idiopathic arthritis (POLY). We hypothesized that gene expression profiles of peripheral blood mononuclear cells (PBMC) from children with each disease would reveal distinct biological pathways when analyzed for significant associations with elevations in two markers of JIA activity, erythrocyte sedimentation rate (ESR) and number of affected joints (joint count, JC).

Methods: PBMC RNA from SJIA and POLY patients was profiled by kinetic PCR to analyze expression of 181 genes, selected for relevance to immune response pathways. Pearson correlation and Student's t-test analyses were performed to identify transcripts significantly associated with clinical parameters (ESR and JC) in SJIA or POLY samples. These transcripts were used to find related biological pathways.

Results: Combining Pearson and t-test analyses, we found 91 ESR-related and 92 JC-related genes in SJIA. For POLY, 20 ESR-related and 0 JC-related genes were found. Using Ingenuity Systems Pathways Analysis, we identified SJIA ESR-related and JC-related pathways. The two sets of pathways are strongly correlated. In contrast, there is a weaker correlation between SJIA and POLY ESR-related pathways. Notably, distinct biological processes were found to correlate with JC in samples from the earlier systemic plus arthritic phase (SAF) of SJIA compared to samples from the later arthritis-predominant phase (AF). Within the SJIA SAF group, IL-10 expression was related to JC, whereas lack of IL-4 appeared to characterize the chronic arthritis (AF) subgroup.

Conclusions: The strong correlation between pathways implicated in elevations of both ESR and JC in SJIA argues that the systemic and arthritic components of the disease are related mechanistically. Inflammatory pathways in SJIA are distinct from those in POLY course JIA, consistent with differences in clinically appreciated target organs. The limited number of ESR-related SJIA genes that also are associated with elevations of ESR in POLY implies that the SJIA associations are specific for SJIA, at least to some degree. The distinct pathways associated with arthritis in early and late SJIA raise the possibility that different immunobiology underlies arthritis over the course of SJIA.

Citing Articles

Comprehensive analysis of juvenile idiopathic arthritis patients' immune characteristics based on bulk and single-cell sequencing data.

Liu M, Gong Y, Lin M, Ma Q Front Mol Biosci. 2024; 11:1359235.

PMID: 38751447 PMC: 11094213. DOI: 10.3389/fmolb.2024.1359235.


Extracellular vesicles in systemic juvenile idiopathic arthritis.

Maller J, Morgan T, Morita M, McCarthy F, Jung Y, Svensson K J Leukoc Biol. 2023; 114(5):387-403.

PMID: 37201912 PMC: 10602196. DOI: 10.1093/jleuko/qiad059.


Single center blind testing of a US multi-center validated diagnostic algorithm for Kawasaki disease in Taiwan.

Kuo H, Hao S, Jin B, Chou C, Han Z, Chang L Front Immunol. 2022; 13:1031387.

PMID: 36263040 PMC: 9575935. DOI: 10.3389/fimmu.2022.1031387.


Application of systems biology-based in silico tools to optimize treatment strategy identification in Still's disease.

Segu-Verges C, Coma M, Kessel C, Smeets S, Foell D, Aldea A Arthritis Res Ther. 2021; 23(1):126.

PMID: 33892792 PMC: 8063416. DOI: 10.1186/s13075-021-02507-w.


Altered signaling in systemic juvenile idiopathic arthritis monocytes.

Macaubas C, Wong E, Zhang Y, Nguyen K, Lee J, Milojevic D Clin Immunol. 2016; 163:66-74.

PMID: 26747737 PMC: 4753112. DOI: 10.1016/j.clim.2015.12.011.


References
1.
Gattorno M, Piccini A, Lasiglie D, Tassi S, Brisca G, Carta S . The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2008; 58(5):1505-15. DOI: 10.1002/art.23437. View

2.
Macaubas C, Nguyen K, Deshpande C, Phillips C, Peck A, Lee T . Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states. Clin Immunol. 2009; 134(2):206-16. PMC: 2818241. DOI: 10.1016/j.clim.2009.09.010. View

3.
Quartier P, Allantaz F, Cimaz R, Pillet P, Messiaen C, Bardin C . A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Ann Rheum Dis. 2010; 70(5):747-54. PMC: 3070271. DOI: 10.1136/ard.2010.134254. View

4.
Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A, Vandergriff J, Rabkin S . The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res. 2004; 33(Database issue):D284-8. PMC: 540032. DOI: 10.1093/nar/gki078. View

5.
Jarvis J, Jiang K, Frank M, Knowlton N, Aggarwal A, Wallace C . Gene expression profiling in neutrophils from children with polyarticular juvenile idiopathic arthritis. Arthritis Rheum. 2009; 60(5):1488-95. PMC: 3063001. DOI: 10.1002/art.24450. View